The Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed) research funding program from the National Institutes of Health supports CCCR to advance the prevention, diagnosis, and treatment of musculoskeletal, rheumatologic, and skin diseases by developing and fostering the implementation of novel methods, metrics, and outcome measures that address critical existing and emerging clinical research needs. Applications are open to US-based research institutions. Applicants may apply for up to 500,000 USD/year for up to 5 years.
Opportunity ID: RFA-AR-24-003.
Letters of intent are due on August 12, 2023 and full applications are due on September 12, 2023.
Menu
